\n<\/p>\n
Introduction<\/span><\/b>\u00a0<\/span><\/p>\n The\u00a0<\/span>synthetic biology market<\/span><\/a>\u00a0size reached USD 19.75 billion in 2025 and is projected to climb to USD 47.88 billion by 2030, advancing at a 19.37% CAGR<\/span>, according to a recent report by Mordor Intelligence. Currently valued at\u00a0USD 19.75 billion, the market is forecast to expand at a compound annual growth rate (CAGR) of approximately\u00a019.37 percent\u00a0through 2030. This steep upward trend reflects both technological progress and increasing adoption of biological manufacturing across industries.<\/span>\u00a0<\/span><\/p>\n Synthetic biology, the engineering discipline that designs and builds biological components and systems, is moving beyond the lab into large-scale biomanufacturing. This shift supports growing interest from healthcare, food, materials, and industrial sectors that see the promise of biology as a manufacturing platform. As the cost of enabling technologies drops and the pace of innovation accelerates, the synthetic biology market is gaining momentum in unprecedented ways.<\/span>\u00a0<\/span><\/p>\n Key Trends\u00a0<\/span><\/b>\u00a0<\/span><\/p>\n Falling Costs in DNA Synthesis<\/span><\/b>\u00a0<\/span><\/p>\n One of the key drivers of synthetic biology market growth is the rapidly decreasing cost of gene synthesis. Innovations in enzymatic DNA synthesis\u00a0are allowing\u00a0multi-kilobase sequences to be made faster and cheaper than before. Traditional cost barriers are being challenged by newer platforms that can deliver longer constructs with higher accuracy. This makes synthetic biological engineering more accessible, enabling more companies and research labs to design and build customized organisms.<\/span>\u00a0<\/span><\/p>\n AI-Powered Protein and Enzyme Design<\/span><\/b>\u00a0<\/span><\/p>\n Artificial intelligence is increasingly woven into synthetic biology workflows, making protein design predictive rather than purely experimental. Large-scale machine learning models trained on vast biological data sets are being used to propose novel enzymes and proteins with optimized functions. By shortening the design\u2013build\u2013test cycle, these AI-driven approaches are fueling faster development of biocatalysts for pharmaceuticals, specialty materials, and industrial biotechnology, boosting the synthetic biology market analysis.<\/span>\u00a0<\/span><\/p>\n Expanding Applications Through Genome Editing<\/span><\/b>\u00a0<\/span><\/p>\n Advances in genome engineering are broadening the application base of synthetic biology. Tools like CRISPR-Cas systems, base editing, and emerging compact editing platforms allow precise manipulation of genomes for therapeutic, agricultural, and industrial use cases. These capabilities enable the creation of new, custom-designed organisms that can perform valuable tasks, supporting synthetic biology market growth in multiple sectors.<\/span>\u00a0<\/span><\/p>\n Demand for Bio-Based Chemicals from Sustainability Goals<\/span><\/b>\u00a0<\/span><\/p>\n Corporate net-zero targets and sustainability goals are pushing demand for bio-based alternatives to traditional petrochemical products. Engineered microbes are being used to produce fuels, chemicals, and materials in a more environmentally friendly way. As businesses aim to reduce their carbon footprint, they are increasingly turning to synthetic biology as a way to manufacture renewables at scale, contributing to synthetic\u00a0biology\u00a0market trends.<\/span>\u00a0<\/span><\/p>\n Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:<\/span><\/b>\u00a0<\/span><\/p>\n https:\/\/www.mordorintelligence.com\/ja\/industry-reports\/synthetic-biology-market?utm_source=emailwire<\/span><\/b><\/a>\u00a0<\/span><\/p>\n Market Segmentation\u00a0<\/span><\/b>\u00a0<\/span><\/p>\n The synthetic biology market can be broken down into various segments that reflect the diverse parts of the value chain. This segmentation helps show how different product types, technologies, applications, and end-users\u00a0are contributing\u00a0to synthetic biology market size and share.<\/span>\u00a0<\/span><\/p>\n By Product<\/span><\/b>\u00a0<\/span><\/p>\n By Technology<\/span><\/b>\u00a0<\/span><\/p>\n By Application<\/span><\/b>\u00a0<\/span><\/p>\n By End-User<\/span><\/b>\u00a0<\/span><\/p>\n By Geography<\/span><\/b>\u00a0<\/span><\/p>\n Each of these segments contributes to overall synthetic biology market growth, and their combined expansion shows how synthetic biology is being adopted across industries.<\/span>\u00a0<\/span><\/p>\n Key Players\u00a0<\/span><\/b>\u00a0<\/span><\/p>\n Several major players dominate the synthetic biology market, covering tools, reagents, and engineered products. Some of the most influential companies include:<\/span>\u00a0<\/span><\/p>\n These companies are actively investing in R&D,\u00a0optimizing\u00a0their platforms, and partnering to expand the potential of synthetic biology. Their roles are central to how the synthetic biology market share is distributed and how future growth will be shaped.<\/span>\u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n Conclusion<\/span><\/b>\u00a0<\/span><\/p>\n The synthetic biology market is poised for significant expansion in the coming years, driven by falling costs for DNA synthesis, AI-driven design, and increasing demand for bio-based solutions across industries. As the market matures, core tools, enabling reagents, and engineered biological outputs will all play a part in realizing the full potential of synthetic biology.<\/span>\u00a0<\/span><\/p>\n However, growth will not happen without navigating challenges. Regulatory frameworks around biosecurity and dual-use concerns, along with talent shortages in computational biology, remain key obstacles. Addressing these will be essential for companies and governments aiming to tap into the synthetic biology market\u2019s full value.<\/span>\u00a0<\/span><\/p>\n Industry related Reports:<\/span><\/b>\u00a0<\/span><\/p>\n Computational Biology\u00a0Market<\/span><\/b><\/a>\u00a0:\u00a0<\/span><\/b>The Computational Biology Market Report provides an overview of the industry by outlining its key segmentations. The market is categorized by application, including cellular and biological simulation (such as computational genomics and related areas), drug discovery and disease modelling (covering target identification and other functions), and preclinical drug development (including pharmacokinetics and\u00a0additional\u00a0processes), among other applications. It is further segmented by tools (such as databases and more), services (including in-house and other service models), end users (ranging from academic institutions to\u00a0additional\u00a0user groups), and geography. All market forecasts are presented in terms of value (USD).<\/span>\u00a0<\/span><\/p>\n Protein Engineering\u00a0Market<\/span><\/b><\/a>\u00a0:\u00a0<\/span><\/b>The Protein Engineering Market Report outlines the sector\u2019s structure by detailing key segments, including protein type (such as insulin, monoclonal antibodies, vaccines, and others), product and service categories (instruments, consumables, and software & services), and major technologies (irrational design, rational design, and hybrid design). It also covers end-user groups, including pharmaceutical and biotechnology companies, among others, and provides a regional breakdown across North America, Europe, and\u00a0additional\u00a0geographies. All market forecasts are presented in terms of value (USD).<\/span>\u00a0<\/span><\/p>\n\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n